DHRM [Dehaier Medical Systems] 6-K/A: DEHAIER MEDICAL SYSTEMS LIMITED AND AFFILIATE INDEX TO

[DEHAIER MEDICAL SYSTEMS LIMITED AND AFFILIATE INDEX TO FINANCIAL STATEMENTS UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS PAGE Condensed Consolidated Interim Balance Sheets as of June 30, 2013 and December 31, 2012 F-2 Condensed Consolidated Interim Statements of Income and Comprehensive Income for the Six Months Ended June 30, 2013 and 2012 F-3 Consolidated Interim Statements of Cash Flows for the] [Dehaier Medical Announces 2013 First Half Year Financial Results BEIJING – August 26, 2013 — Dehaier Medical Systems Ltd. (Nasdaq: DHRM) Mr. Ping Chen, Chief Executive Officer of Dehaier Medical, stated, "We are pleased to have expanded into China’s burgeoning sleep respiratory market by entering into a strategic agreement with an Israeli medical signal processing company. As WideMed’s exclusive partner] []

SEED [Origin Agritech] 6-K: (Original Filing)

[Origin Agritech Limited Reports Unaudited First Quarter Financial Results Origin Agritech Limited (NASDAQ GS: SEED) (“Origin”, or the “Company”) BEIJING--/PRNewswire/--February, 2014-- FINANCIAL RESULTS OVERVIEW During the first quarter of fiscal year 2014, the Company generated revenues of RMB 20.4 million (US$3.3 million) compared with RMB 22.7 million in the three months ended December 31, 2012. The revenues this quarter were] []

By | 2016-03-31T20:57:42+00:00 February 21st, 2014|Categories: Chinese Stocks, SEC Original, SEED|Tags: , , , , , |0 Comments

DL [China Distance Education] F-3: (Original Filing)

[SUBJECT TO COMPLETION, DATED FEBRUARY , 2014 PRELIMINARY PROSPECTUS American Depositary Shares China Distance Education Holdings Limited Representing Ordinary Shares We are offering American depositary shares, or ADSs, and the selling shareholders identified in this prospectus are offering an additional ADSs. Each ADS represents four ordinary shares, par value US$0.0001 per ordinary share. We will not receive any proceeds from] [21 February, 2014 China Distance Education Holdings Limited 18th Floor, Xueyuan International Tower 1 Zhichun Road, Haidian District Beijing 100083 People’s Republic of China DIRECT LINE: E-MAIL OUR REF: YOUR REF: 852 2842 9531 Anna.Chong@conyersdill.com AC/al/#5279482 (M#879152) Dear Sirs, China Distance Education Holdings Limited (the “Company”) F-3, Commission Registration Statement Securities Act Ordinary Shares We have acted as special legal] [February 21, 2014 China Distance Education Holdings Limited 18th Floor, Xueyuan International Tower 1 Zhichun Road, Haidian District Beijing 100083, People’s Republic of China Re: American Depositary Shares (the “ADSs”), each representing four ordinary shares of China Distance Education Holdings Limited (the “Company”) Ladies and Gentlemen: Respectfully submitted, EX-8.1 3 d678659dex81.htm EX-8.1] [34/F, Tower 3, China Central Place, 77 Jianguo Road, Beijing 100025, China Telephone: (86-10) 5809-1000 Facsimile: (86-10) 5809-1100 February 21, 2014 To: China Distance Education Holdings Limited 18th Floor, Xueyuan International Tower 1 Zhichun Road. Haidian District Beijing 100083, China Ladies and Gentlemen, In rendering this opinion, we have examined the originals, or copies certified or otherwise identified to our] [Consent Of Independent Registered Public Accounting Firm We consent to the incorporation by reference in this Registration Statement on Form F-3 of our reports dated December 27, 2013, relating to the consolidated financial statements of China Distance Education Holdings Limited, its subsidiaries, its variable interest entity and the subsidiaries of its variable interest entity (collectively, the “Group”) and the financial]

By | 2016-03-18T10:00:27+00:00 February 21st, 2014|Categories: Chinese Stocks, DL, SEC Original|Tags: , , , , , |0 Comments

SEED [Origin Agritech] 6-K: Origin Agritech Limited Reports Unaudited First Quarter Financial

[Origin Agritech Limited Reports Unaudited First Quarter Financial Results Origin Agritech Limited (NASDAQ GS: SEED) (“Origin”, or the “Company”) BEIJING--/PRNewswire/--February, 2014-- FINANCIAL RESULTS OVERVIEW During the first quarter of fiscal year 2014, the Company generated revenues of RMB 20.4 million (US$3.3 million) compared with RMB 22.7 million in the three months ended December 31, 2012. The revenues this quarter were] []

By | 2016-03-31T20:59:18+00:00 February 21st, 2014|Categories: Chinese Stocks, SEED, Webplus ver|Tags: , , , , , |0 Comments

DL [China Distance Education] F-3: SUBJECT TO COMPLETION, DATED FEBRUARY , 2014 PRELIMINARY

[SUBJECT TO COMPLETION, DATED FEBRUARY , 2014 PRELIMINARY PROSPECTUS American Depositary Shares China Distance Education Holdings Limited Representing Ordinary Shares We are offering American depositary shares, or ADSs, and the selling shareholders identified in this prospectus are offering an additional ADSs. Each ADS represents four ordinary shares, par value US$0.0001 per ordinary share. We will not receive any proceeds from] [21 February, 2014 China Distance Education Holdings Limited 18th Floor, Xueyuan International Tower 1 Zhichun Road, Haidian District Beijing 100083 People’s Republic of China DIRECT LINE: E-MAIL OUR REF: YOUR REF: 852 2842 9531 Anna.Chong@conyersdill.com AC/al/#5279482 (M#879152) Dear Sirs, China Distance Education Holdings Limited (the “Company”) F-3, Commission Registration Statement Securities Act Ordinary Shares We have acted as special legal] [February 21, 2014 China Distance Education Holdings Limited 18th Floor, Xueyuan International Tower 1 Zhichun Road, Haidian District Beijing 100083, People’s Republic of China Re: American Depositary Shares (the “ADSs”), each representing four ordinary shares of China Distance Education Holdings Limited (the “Company”) Ladies and Gentlemen: Respectfully submitted, EX-8.1 3 d678659dex81.htm EX-8.1] [34/F, Tower 3, China Central Place, 77 Jianguo Road, Beijing 100025, China Telephone: (86-10) 5809-1000 Facsimile: (86-10) 5809-1100 February 21, 2014 To: China Distance Education Holdings Limited 18th Floor, Xueyuan International Tower 1 Zhichun Road. Haidian District Beijing 100083, China Ladies and Gentlemen, In rendering this opinion, we have examined the originals, or copies certified or otherwise identified to our] [Consent Of Independent Registered Public Accounting Firm We consent to the incorporation by reference in this Registration Statement on Form F-3 of our reports dated December 27, 2013, relating to the consolidated financial statements of China Distance Education Holdings Limited, its subsidiaries, its variable interest entity and the subsidiaries of its variable interest entity (collectively, the “Group”) and the financial]

By | 2016-03-18T10:01:57+00:00 February 21st, 2014|Categories: Chinese Stocks, DL, Webplus ver|Tags: , , , , , |0 Comments

TPI [TIANYIN PHARMACEUTICAL] 8-K: (Original Filing)

[TPI Reports Second Quarter Fiscal Year 2014 Financial Results CHENGDU, China, February 14, 2014 -- Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced financial results for the second quarter of fiscal year 2014. Second Quarter Fiscal 2014 Ended December 31,] [Tianyin Pharmaceutical Inc. Second Quarter Fiscal Year 2014 Financial Results Conference Call February 14, 2014 Operator I will now turn the presentation over to James Tong, CFO of the Company. Dr. Tong: Second Quarter of Fiscal 2014 Ended December 31, 2013 Financial Highlights: ● Revenue was $13.9 million versus $17.6 million in the second quarter FY 2013, a decrease of] [CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K Current Report February 14, 2014 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction Identification No.) (IRS Employer of incorporation) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 o o o]

By | 2016-03-19T15:53:50+00:00 February 21st, 2014|Categories: Chinese Stocks, SEC Original, TPI|Tags: , , , , , |0 Comments

TPI [TIANYIN PHARMACEUTICAL] 8-K: TPI Reports Second Quarter Fiscal Year 2014 Financial

[TPI Reports Second Quarter Fiscal Year 2014 Financial Results CHENGDU, China, February 14, 2014 -- Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced financial results for the second quarter of fiscal year 2014. Second Quarter Fiscal 2014 Ended December 31,] [Tianyin Pharmaceutical Inc. Second Quarter Fiscal Year 2014 Financial Results Conference Call February 14, 2014 Operator I will now turn the presentation over to James Tong, CFO of the Company. Dr. Tong: Second Quarter of Fiscal 2014 Ended December 31, 2013 Financial Highlights: ● Revenue was $13.9 million versus $17.6 million in the second quarter FY 2013, a decrease of] [CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K Current Report February 14, 2014 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction Identification No.) (IRS Employer of incorporation) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 o o o]

By | 2016-03-19T15:55:05+00:00 February 21st, 2014|Categories: Chinese Stocks, TPI, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar